Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares increased 5.55% in pre-market trading to $585.
Exelixis, Inc. (NASDAQ:EXEL) announced the pricing of its underwritten public offering of 25,000,000 shares of newly issued common stock at a price to the …
Apple Inc. (NASDAQ:AAPL) shares slipped -6% in pre-market trading to $122.
Exelixis, Inc. (NASDAQ:EXEL) announced that it plans to offer, subject to market and other conditions, 20,000,000 shares of its common stock in an underwritten …
GoPro Inc (NASDAQ:GPRO) shares are up 2.40% in pre-market trading to $58.
Exelixis, Inc. (NASDAQ:EXEL) announced positive top-line results from the primary analysis of METEOR, the phase 3 pivotal trial comparing cabozantinib to everolimus in …
Exelixis, Inc. (NASDAQ:EXEL) announced the appointment of Christopher J.
Exelixis, Inc. (NASDAQ:EXEL) announced the initiation of a phase 1 trial of cabozantinib in combination with nivolumab alone or in combination with nivolumab plus …
Exelixis, Inc. (NASDAQ:EXEL) announced updated positive results for cobimetinib, an Exelixis-discovered investigational compound, in combination with vemurafenib for the treatment of patients with previously …
Cowen’s healthcare analyst Eric Schmidt weighed in today with his thoughts on Exelixis, Inc. (NASDAQ:EXEL), after the company reported its fourth-quarter results and business update.
